196 related articles for article (PubMed ID: 4015069)
1. In vitro activity of Sch 34343 and cefbuperazone against anaerobic bacteria.
Shafran SD; Wong J; Chow AW
Antimicrob Agents Chemother; 1985 May; 27(5):749-52. PubMed ID: 4015069
[TBL] [Abstract][Full Text] [Related]
2. In vitro activity of cefbuperazone, a new cephamycin, against anaerobic bacteria.
Prabhala RH; Thadepalli H; Rao B; Bansal MB; Marshall R
Antimicrob Agents Chemother; 1985 Apr; 27(4):640-2. PubMed ID: 4004195
[TBL] [Abstract][Full Text] [Related]
3. Comparative in vitro activity of cefbuperazone against anaerobic bacteria isolated from community hospitals.
Goldstein EJ; Citron DM
Antimicrob Agents Chemother; 1985 Feb; 27(2):162-6. PubMed ID: 3985600
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of cefbuperazone against anaerobic bacteria.
Wexler H; Carter WT; Harris BH; Finegold SM
Antimicrob Agents Chemother; 1985 Apr; 27(4):674-6. PubMed ID: 3847274
[TBL] [Abstract][Full Text] [Related]
5. Activity of cefotetan against anaerobic bacteria.
Dias MB; Jacobus NV; Tally FP; Gorbach SL
Diagn Microbiol Infect Dis; 1986 Apr; 4(4):359-63. PubMed ID: 3457672
[TBL] [Abstract][Full Text] [Related]
6. In vitro activity of cefbuperazone against Bacteroides spp.
Dias MB; Jacobus NV; Gorbach SL; Tally FP
Antimicrob Agents Chemother; 1985 Jun; 27(6):968-70. PubMed ID: 4026272
[TBL] [Abstract][Full Text] [Related]
7. Susceptibility of anaerobic bacteria to Sch 34343 and other antibiotics.
Glupczynski Y; Gordts B; van der Linden MP; Labbé M; Yourassowsky E; Butzler JP
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():193-8. PubMed ID: 4030548
[TBL] [Abstract][Full Text] [Related]
8. Activity of cefmetazole against anaerobic bacteria.
Cornick NA; Jacobus NV; Gorbach SL
Antimicrob Agents Chemother; 1987 Dec; 31(12):2010-2. PubMed ID: 3481541
[TBL] [Abstract][Full Text] [Related]
9. Susceptibility of anaerobic bacteria to Sch 34343 and other beta-lactam antibiotics.
Jacobus NV; Tally FP; Gorbach SL
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():189-91. PubMed ID: 4030547
[TBL] [Abstract][Full Text] [Related]
10. BMY28142, cefbuperazone (T-1982), and Sch 34343. Antimicrobial activity against 94 anaerobes compared to seven other antimicrobial agents.
Jones RN; Barry AL; Packer RR
Diagn Microbiol Infect Dis; 1985 May; 3(3):263-8. PubMed ID: 3838925
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro activities of ABT-773 against 362 clinical isolates of anaerobic bacteria.
Citron DM; Appleman MD
Antimicrob Agents Chemother; 2001 Jan; 45(1):345-8. PubMed ID: 11120995
[TBL] [Abstract][Full Text] [Related]
12. In vitro activity of cefbuperazone compared with that of other new beta-lactam agents against anaerobic gram-negative bacilli and contribution of beta-lactamase to resistance.
Del Bene VE; Carek PJ; Twitty JA; Burkey LJ
Antimicrob Agents Chemother; 1985 May; 27(5):817-20. PubMed ID: 3874597
[TBL] [Abstract][Full Text] [Related]
13. Comparative in-vitro activity of Sch 34343 and other antimicrobial agents against anaerobic bacteria.
Nord CE; Olsson-Liljequist B
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():183-8. PubMed ID: 2863246
[TBL] [Abstract][Full Text] [Related]
14. [In vitro activities of sulopenem, a new parenteral penem, against anaerobes].
Watanabe K; Kato N; Tanaka-Bandoh K; Tanaka Y; Kato H; Ueno K
Jpn J Antibiot; 1996 Apr; 49(4):367-76. PubMed ID: 8786627
[TBL] [Abstract][Full Text] [Related]
15. Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.
Goldstein EJ; Citron DM; Cherubin CE; Hillier SL
J Antimicrob Chemother; 1993 Mar; 31(3):363-72. PubMed ID: 8486570
[TBL] [Abstract][Full Text] [Related]
16. N-formimidoyl thienamycin (MK0787): in vitro activity against anaerobic bacteria.
Martin DA; Sanders CV; Marier RL
Antimicrob Agents Chemother; 1982 Jan; 21(1):168-9. PubMed ID: 6952818
[TBL] [Abstract][Full Text] [Related]
17. Comparative in-vitro activity of Sch 34343 for a wide spectrum of clinically significant anaerobic bacteria.
Wells CL; Wilkins TD
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():177-82. PubMed ID: 4030546
[TBL] [Abstract][Full Text] [Related]
18. In vitro activity of flomoxef compared to moxalactam, cefoxitin, cefotaxime, and clindamycin against anaerobes.
Werner H; Heizmann W; Luft G
Arzneimittelforschung; 1988 Nov; 38(11):1553-6. PubMed ID: 3214438
[TBL] [Abstract][Full Text] [Related]
19. European collaborative study of reproducibility of quantitative sensitivity testing of anaerobes.
King A; Phillips I
J Antimicrob Chemother; 1988 Apr; 21(4):425-38. PubMed ID: 3378957
[TBL] [Abstract][Full Text] [Related]
20. High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan.
Teng LJ; Hsueh PR; Tsai JC; Liaw SJ; Ho SW; Luh KT
Antimicrob Agents Chemother; 2002 Sep; 46(9):2908-13. PubMed ID: 12183246
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
